Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10643872rdf:typepubmed:Citationlld:pubmed
pubmed-article:10643872lifeskim:mentionsumls-concept:C0680063lld:lifeskim
pubmed-article:10643872lifeskim:mentionsumls-concept:C0024554lld:lifeskim
pubmed-article:10643872lifeskim:mentionsumls-concept:C0034693lld:lifeskim
pubmed-article:10643872lifeskim:mentionsumls-concept:C1261210lld:lifeskim
pubmed-article:10643872lifeskim:mentionsumls-concept:C0012052lld:lifeskim
pubmed-article:10643872lifeskim:mentionsumls-concept:C0878751lld:lifeskim
pubmed-article:10643872lifeskim:mentionsumls-concept:C0879626lld:lifeskim
pubmed-article:10643872lifeskim:mentionsumls-concept:C0010339lld:lifeskim
pubmed-article:10643872lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:10643872lifeskim:mentionsumls-concept:C1442162lld:lifeskim
pubmed-article:10643872lifeskim:mentionsumls-concept:C1550718lld:lifeskim
pubmed-article:10643872pubmed:issue3lld:pubmed
pubmed-article:10643872pubmed:dateCreated2000-2-3lld:pubmed
pubmed-article:10643872pubmed:abstractTextThe objective of this study was to determine the susceptible days for the adverse effects of di-n-butyl phthalate (DBP) on development of reproductive system in male offspring following maternal administration on successive 3-day period during late pregnancy. Pregnant rats were given DBP by gastric intubation at 1000 or 1500 mg/kg on days 12-14 or 18-20 of pregnancy or at 500, 1000 or 1500 mg/kg on days 15-17 of pregnancy. A significant decrease in the maternal body weight gain and/or food consumption was found in the DBP-treated groups regardless of the days on which DBP at 1000 and 1500 mg/kg was given. A significant increase in the number of resorptions per litter was found in the groups given DBP at 1500 mg/kg on days 12-14 and 15-17 of pregnancy. The weights of male and female fetuses were significantly decreased in the groups given DBP at 1000 and 1500 mg/kg on days 12-14 and 18-20 and at 1500 mg/kg on days 15-17. A significant increase in the incidence of fetuses with undescended testes was found at 1500 mg/kg on days 12-14 and at all doses on days 15-17. A significant decrease in the anogenital distance (AGD) of male fetuses was observed in the groups treated with DBP regardless of the days of treatment. The AGD/body weight ratio in male fetuses was significantly reduced in the groups given DBP on days 15-17, but neither on days 12-14 nor 18-20. The AGD of female fetuses in the DBP-treated groups was comparable to that in the control group. It was concluded that period of days 15-17 of pregnancy was the most susceptible for DBP-induced undescended testes and decreased AGD in male offspring.lld:pubmed
pubmed-article:10643872pubmed:languageenglld:pubmed
pubmed-article:10643872pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10643872pubmed:citationSubsetIMlld:pubmed
pubmed-article:10643872pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10643872pubmed:statusMEDLINElld:pubmed
pubmed-article:10643872pubmed:monthJanlld:pubmed
pubmed-article:10643872pubmed:issn0378-4274lld:pubmed
pubmed-article:10643872pubmed:authorpubmed-author:KawashimaKKlld:pubmed
pubmed-article:10643872pubmed:authorpubmed-author:FOGJJlld:pubmed
pubmed-article:10643872pubmed:authorpubmed-author:MiyawakiEElld:pubmed
pubmed-article:10643872pubmed:issnTypePrintlld:pubmed
pubmed-article:10643872pubmed:day5lld:pubmed
pubmed-article:10643872pubmed:volume111lld:pubmed
pubmed-article:10643872pubmed:ownerNLMlld:pubmed
pubmed-article:10643872pubmed:authorsCompleteYlld:pubmed
pubmed-article:10643872pubmed:pagination271-8lld:pubmed
pubmed-article:10643872pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10643872pubmed:meshHeadingpubmed-meshheading:10643872...lld:pubmed
pubmed-article:10643872pubmed:meshHeadingpubmed-meshheading:10643872...lld:pubmed
pubmed-article:10643872pubmed:meshHeadingpubmed-meshheading:10643872...lld:pubmed
pubmed-article:10643872pubmed:meshHeadingpubmed-meshheading:10643872...lld:pubmed
pubmed-article:10643872pubmed:meshHeadingpubmed-meshheading:10643872...lld:pubmed
pubmed-article:10643872pubmed:meshHeadingpubmed-meshheading:10643872...lld:pubmed
pubmed-article:10643872pubmed:meshHeadingpubmed-meshheading:10643872...lld:pubmed
pubmed-article:10643872pubmed:meshHeadingpubmed-meshheading:10643872...lld:pubmed
pubmed-article:10643872pubmed:meshHeadingpubmed-meshheading:10643872...lld:pubmed
pubmed-article:10643872pubmed:meshHeadingpubmed-meshheading:10643872...lld:pubmed
pubmed-article:10643872pubmed:meshHeadingpubmed-meshheading:10643872...lld:pubmed
pubmed-article:10643872pubmed:meshHeadingpubmed-meshheading:10643872...lld:pubmed
pubmed-article:10643872pubmed:meshHeadingpubmed-meshheading:10643872...lld:pubmed
pubmed-article:10643872pubmed:year2000lld:pubmed
pubmed-article:10643872pubmed:articleTitleCritical period for adverse effects on development of reproductive system in male offspring of rats given di-n-butyl phthalate during late pregnancy.lld:pubmed
pubmed-article:10643872pubmed:affiliationNational Institute of Health Sciences, Osaka Branch, Japan. ema@nihs.go.jplld:pubmed
pubmed-article:10643872pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10643872pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10643872lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10643872lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10643872lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10643872lld:pubmed